Mildronate (Meldonium Dihydrate)

Meldonium, the active ingredient in Mildronate, is a metabolic modulator presented as a sterile aqueous solution for intravenous use. It is employed to support cardiac energy metabolism in patients with certain cardiovascular conditions.

GNH USA supplies Mildronate as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across all markets.

Mildronate (meldonium) is used in cardiovascular disorders to improve myocardial energy metabolism.

- Ischemic heart disease: improves myocardial efficiency and reduces angina frequency. - Chronic heart failure: supports cardiac output and exercise tolerance. - Peripheral arterial disease: enhances peripheral blood flow and reduces claudication symptoms.

Mildronate may be associated with several adverse reactions, ranging from mild to serious.

Common Side Effects: - Nausea: mild gastrointestinal upset reported in some patients. - Headache: transient head discomfort observed after administration. - Dizziness: occasional sensation of light‑headedness. - Injection site pain: local discomfort at the infusion site.

Serious or Rare Side Effects: - Allergic reactions: including rash, urticaria, or anaphylaxis. - Hypotension: marked drop in blood pressure requiring monitoring. - Cardiac arrhythmias: irregular heart rhythms observed rarely. - Liver enzyme elevation: abnormal hepatic function tests in isolated cases.

When prescribing Mildronate, clinicians should observe several precautionary measures.

- Cardiac monitoring: assess heart function regularly during therapy. - Renal impairment: use with caution and adjust if necessary. - Hepatic dysfunction: monitor liver enzymes and adjust treatment as needed. - Hypersensitivity: discontinue immediately if allergic reaction occurs. - Concomitant medications: review for potential interactions before initiating therapy. - Store at ambient temperature: keep in original packaging, protect from moisture and light.

Mildronate can interact with other medicines, requiring attention to the following.

Major Interactions (Avoid): - Strong CYP450 inducers: may significantly reduce therapeutic effect. - Concurrent use with other metabolic modulators: risk of additive metabolic effects.

Moderate Interactions (Monitor Closely): - Anticoagulants: potential increased bleeding risk. - Diuretics: may enhance hypotensive effect. - Antihypertensive agents: monitor blood pressure closely.